LN1418151
98% , 1132709-16-0
Pack Size | Price | Stock | Quantity |
100mg | RMB2671.20 | In Stock |
|
others | Enquire |
Update time: 2022-07-08
PRODUCT Properties
Density | 1.214±0.06 g/cm3(Predicted) |
solubility | Acetonitrile (Slightly), DMSO (Slightly), Methanol (Slightly) |
pka | 9.66±0.43(Predicted) |
form | Solid |
color | White to Off-White |
Stability: | Hygroscopic, Light sensitive, Moisture sensitive |
Description and Uses
(1S,3R)-Bortezomib is an diastereomer of Bortezomib (B675700), the first proteasome inhibitor to be approved by the US FDA for multiple myeloma, a blood cancer. A reversible inhibitor of the 26S proteasome-a barrel-shaped multiprotein particle found in the nucleus and cytosol of all eukaryotic cells. Targets the ubiquitin-proteasome pathway